Drug Resistance, Bacterial
"Drug Resistance, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
| Descriptor ID |
D024881
|
| MeSH Number(s) |
G06.099.225 G06.225.347 G07.690.773.984.269.347
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Bacterial" by people in this website by year, and whether "Drug Resistance, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 7 | 7 |
| 2004 | 1 | 6 | 7 |
| 2005 | 9 | 9 | 18 |
| 2006 | 6 | 12 | 18 |
| 2007 | 5 | 6 | 11 |
| 2008 | 4 | 9 | 13 |
| 2009 | 2 | 6 | 8 |
| 2010 | 4 | 7 | 11 |
| 2011 | 7 | 7 | 14 |
| 2012 | 8 | 4 | 12 |
| 2013 | 8 | 11 | 19 |
| 2014 | 9 | 9 | 18 |
| 2015 | 5 | 14 | 19 |
| 2016 | 7 | 12 | 19 |
| 2017 | 4 | 11 | 15 |
| 2018 | 8 | 10 | 18 |
| 2019 | 5 | 7 | 12 |
| 2020 | 6 | 7 | 13 |
| 2021 | 5 | 8 | 13 |
| 2022 | 1 | 12 | 13 |
| 2023 | 1 | 7 | 8 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.
-
Source tracking of extensively drug resistant Salmonella Typhi in food and raw vegetables using molecular approaches. J Infect Dev Ctries. 2024 Feb 29; 18(2):227-234.
-
LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0106923.
-
Cut-off value of clarithromycin resistance in the treatment of Helicobacter pylori infection: how low is low? Gut. 2024 Jan 05; 73(2):374-375.
-
Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops. J Biol Chem. 2024 Jan; 300(1):105493.
-
Predicting Antibiotic Susceptibility Among Patients With Recurrent Urinary Tract Infection Using a Prior Culture. J Urol. 2024 Jan; 211(1):144-152.
-
Structural biology of MCR-1-mediated resistance to polymyxin antibiotics. Curr Opin Struct Biol. 2023 10; 82:102647.
-
Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States. Clin Infect Dis. 2023 06 08; 76(11):2038-2039.
-
Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients. PLoS One. 2023; 18(5):e0285427.
-
Gene network interaction analysis to elucidate the antimicrobial resistance mechanisms in the Clostridiumdifficile. Microb Pathog. 2023 May; 178:106083.
-
Response to: a true point-of-care molecular testing method for tailored therapy for Helicobacter pylori eradication. Expert Rev Gastroenterol Hepatol. 2023 03; 17(3):311.